Literature DB >> 2546845

Hypoglycaemia induced by antibodies to insulin receptor following a bone marrow transplantation in an immunodeficient child.

N Rochet1, S Blanche, J C Carel, A Fischer, F L Deist, C Griscelli, E Van Obberghen, Y Le Marchand-Brustel.   

Abstract

Severe hypoglycaemia developed seven months after a bone marrow transplantation in a child with severe combined immunodeficiency. His serum exerted potent insulin-like activity: (a) it stimulated insulin receptor autophosphorylation and kinase activity in cell-free systems, this effect being additive to insulin; (b) it increased glucose transport in isolated soleus muscle. These insulin-like effects were due to immunoglobulins against the insulin receptor. Indeed, the patient serum immunoprecipitated human or murine insulin receptors from different tissues and inhibited insulin binding to receptor on human IM-9 lymphocytes. After corticoids and immunosuppressive therapy by azathioprine, the patient hypoglycaemic episodes disappeared, and concomitantly, the antibodies to insulin receptor were no longer detected, as judged by both immunoprecipitation of insulin receptor and stimulation of glucose transport.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2546845     DOI: 10.1007/BF00265089

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  29 in total

1.  Multiple restriction fragment length polymorphisms at the insulin receptor locus: a highly informative marker for linkage analysis.

Authors:  S C Elbein; L Corsetti; A Ullrich; M A Permutt
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis.

Authors:  D A McClain; H Maegawa; J Lee; T J Dull; A Ulrich; J M Olefsky
Journal:  J Biol Chem       Date:  1987-10-25       Impact factor: 5.157

4.  Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin.

Authors:  C K Chou; T J Dull; D S Russell; R Gherzi; D Lebwohl; A Ullrich; O M Rosen
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

5.  Insulin receptor tyrosine kinase is defective in skeletal muscle of insulin-resistant obese mice.

Authors:  Y Le Marchand-Brustel; T Grémeaux; R Ballotti; E Van Obberghen
Journal:  Nature       Date:  1985 Jun 20-26       Impact factor: 49.962

6.  Hypoglycaemia due to an insulin-receptor antibody in Hodgkin's disease.

Authors:  E G Walters; J M Tavaré; R M Denton; G Walters
Journal:  Lancet       Date:  1987-01-31       Impact factor: 79.321

7.  Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose.

Authors:  L Ellis; E Clauser; D O Morgan; M Edery; R A Roth; W J Rutter
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

8.  Biosynthetic labeling of insulin receptor: studies of subunits in cultured human IM-9 lymphocytes.

Authors:  E Van Obberghen; M Ksauga; A Le Cam; J A Hedo; A Itin; L C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

9.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

Authors:  H M Shulman; K M Sullivan; P L Weiden; G B McDonald; G E Striker; G E Sale; R Hackman; M S Tsoi; R Storb; E D Thomas
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

10.  Insulin and rabbit anti-insulin receptor antibodies stimulate additively the intrinsic receptor kinase activity.

Authors:  G Ponzio; J Dolais-Kitabgi; D Louvard; N Gautier; B Rossi
Journal:  EMBO J       Date:  1987-02       Impact factor: 11.598

View more
  3 in total

1.  Autoantibodies to the insulin receptor are infrequent findings in type 1 (insulin-dependent) diabetes mellitus of recent onset.

Authors:  N Rochet; J L Sadoul; B Ferrua; J Kubar; J F Tanti; P Bougnères; B Vialettes; E Van Obberghen; Y Le Marchand-Brustel; P Freychet
Journal:  Diabetologia       Date:  1990-07       Impact factor: 10.122

2.  Autoimmune polyendocrine failure--type 1 (insulin-dependent) diabetes mellitus and hypothyroidism--after allogeneic bone marrow transplantation in a patient with lymphoblastic leukaemia.

Authors:  B Vialettes; D Maraninchi; M P San Marco; F Birg; A M Stoppa; C Mattei-Zevaco; C Thivolet; L Hermitte; P Vague; P Mercier
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

Review 3.  Type B insulin resistance developing during interferon-alpha therapy.

Authors:  Amanda L Daniel; Josetta L Houlihan; Janice S Blum; James P Walsh
Journal:  Endocr Pract       Date:  2009-03       Impact factor: 3.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.